Corteva (NYSE:CTVA) Receives “Buy” Rating from Argus

Corteva (NYSE:CTVA)‘s stock had its “buy” rating reiterated by Argus in a note issued to investors on Friday, Benzinga reports. They presently have a $91.00 price target on the stock. Argus’ price target points to a potential upside of 11.55% from the stock’s previous close.

Other research analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Royal Bank Of Canada reissued an “outperform” rating and set a $103.00 price objective on shares of Corteva in a report on Wednesday. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Finally, Morgan Stanley boosted their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $91.90.

Corteva Stock Up 0.7%

CTVA opened at $81.58 on Friday. The stock has a market cap of $54.43 billion, a price-to-earnings ratio of 54.02, a price-to-earnings-growth ratio of 2.49 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm’s fifty day moving average is $83.23 and its 200 day moving average is $81.46. Corteva has a fifty-two week low of $60.53 and a fifty-two week high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s quarterly revenue was down 1.2% on a year-over-year basis. During the same period last year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts forecast that Corteva will post 3.72 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Corteva

Institutional investors have recently modified their holdings of the stock. Parkside Financial Bank & Trust increased its holdings in Corteva by 3.2% during the 2nd quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock valued at $316,000 after purchasing an additional 116 shares during the period. William B. Walkup & Associates Inc. increased its stake in shares of Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after buying an additional 126 shares during the period. HB Wealth Management LLC raised its holdings in shares of Corteva by 0.5% during the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock valued at $2,018,000 after acquiring an additional 128 shares in the last quarter. Wilkerson Advisory Group LLC boosted its holdings in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after acquiring an additional 133 shares in the last quarter. Finally, AdvisorNet Financial Inc raised its holdings in Corteva by 2.4% in the 1st quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after purchasing an additional 135 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

About Corteva

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.